Abstract |
Primary effusion lymphomas (PEL), rare lymphomas associated with Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) infection, present as malignant lymphomatous effusions in body cavities. We have recently found that PEL effusions contain high levels of vascular endothelial growth factor/ vascular permeability factor ( VEGF/VPF). VEGF/VPF, an important regulator of tumor-angiogenesis in vivo, exerts its effects acting through the receptors KDR/Flk-1 and Flt-1 on the endothelial cell membrane. In vitro, the PEL cell lines BC-1, BCP-1 and BCBL-1 produce high levels of VEGF. RT-PCR analysis of RNA from the PEL cell lines amplified the three VEGF/VPF secreted isoforms, VEGF/VPF(121), VEGF/VPF(145) and VEGF/VPF(165). Two of the PEL cell lines express the VEGF/ VPF receptor Flt-1, but VEGF did not stimulate proliferation in these cells. SCID/beige mice inoculated intraperitoneally with BCBL-1 cells developed effusion lymphoma of human cell origin with prominent bloody ascites. In contrast, none of the mice treated with a neutralizing anti-human VEGF/VPF antibody developed ascites and effusion lymphoma. Although the precise mechanisms by which VEGF/VPF can promote vascular permeability are not fully understood, VEGF/VPF stimulation of vascular leakage may be critical to the pathogenesis of PEL.
|
Authors | Y Aoki, G Tosato |
Journal | Leukemia & lymphoma
(Leuk Lymphoma)
Vol. 41
Issue 3-4
Pg. 229-37
(Apr 2001)
ISSN: 1042-8194 [Print] United States |
PMID | 11378536
(Publication Type: Journal Article, Review)
|
Chemical References |
- Endothelial Growth Factors
- Lymphokines
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
|
Topics |
- Animals
- Endothelial Growth Factors
(adverse effects, metabolism, physiology)
- Herpesviridae Infections
(complications)
- Herpesvirus 8, Human
- Humans
- Lymphokines
(adverse effects, metabolism, physiology)
- Lymphoma, AIDS-Related
(etiology, metabolism)
- Peritoneal Neoplasms
(etiology, metabolism)
- Pleural Effusion, Malignant
(etiology, metabolism)
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
|